TNSN99210A1 - Identification de genotypes du virus sen - Google Patents
Identification de genotypes du virus senInfo
- Publication number
- TNSN99210A1 TNSN99210A1 TNTNSN99210A TNSN99210A TNSN99210A1 TN SN99210 A1 TNSN99210 A1 TN SN99210A1 TN TNSN99210 A TNTNSN99210 A TN TNSN99210A TN SN99210 A TNSN99210 A TN SN99210A TN SN99210 A1 TNSN99210 A1 TN SN99210A1
- Authority
- TN
- Tunisia
- Prior art keywords
- acid molecule
- nucleic acid
- virus
- genome
- relates
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 108020004707 nucleic acids Proteins 0.000 abstract 6
- 102000039446 nucleic acids Human genes 0.000 abstract 6
- 150000007523 nucleic acids Chemical class 0.000 abstract 6
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 230000003612 virological effect Effects 0.000 abstract 3
- 230000000295 complement effect Effects 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- -1 PREFERABLY Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000003212 astringent agent Substances 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI982437 IT1303732B1 (it) | 1998-11-10 | 1998-11-10 | Molecole di acido nucleico che rappresentano un virus trasmissibileper via parenterale. |
| ITMI990923 IT1312552B1 (it) | 1999-04-30 | 1999-04-30 | Molecole di acido nucleico che rappresentano un virus trasmissibileper via parenterale |
| EP99830298 | 1999-05-14 | ||
| EP99113932 | 1999-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN99210A1 true TNSN99210A1 (fr) | 2005-11-10 |
Family
ID=27443821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNTNSN99210A TNSN99210A1 (fr) | 1998-11-10 | 1999-11-08 | Identification de genotypes du virus sen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1137779A2 (es) |
| JP (1) | JP2002529092A (es) |
| AR (1) | AR021143A1 (es) |
| AU (1) | AU1381600A (es) |
| NO (1) | NO20012276L (es) |
| PE (1) | PE20001331A1 (es) |
| TN (1) | TNSN99210A1 (es) |
| WO (1) | WO2000028039A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL364797A1 (en) * | 1999-12-10 | 2004-12-13 | Roche Diagnostics Gmbh | Hepatitis virus sentinel virus i (svi) |
| DE10007234A1 (de) * | 2000-02-17 | 2001-10-18 | Sension Biolog Detektions Und | Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems |
| DE10144346A1 (de) * | 2001-09-10 | 2003-04-03 | Deutsches Krebsforsch | TT-Virus-Sequenzen in menschlichen Tumorgeweben, Mittel zu deren Nachweis sowie Tumortherapie |
| DK2399928T3 (da) * | 2010-06-23 | 2018-01-29 | Deutsches Krebsforsch | Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet |
| US9676828B2 (en) | 2010-06-23 | 2017-06-13 | Deutsches Krebsforschungszentrum | Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| EP2585477B1 (en) * | 2010-06-23 | 2018-05-30 | Deutsches Krebsforschungszentrum | Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
| US20110318363A1 (en) | 2010-06-23 | 2011-12-29 | Deutsches Krebsforschungszentrum | Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2298103A1 (en) * | 1997-07-25 | 1999-02-04 | Tamura, Ryoji | Non-b, non-c, non-g hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| WO1999058638A2 (en) * | 1998-05-13 | 1999-11-18 | Innogenetics N.V. | Sequences of tt viruses for use in diagnosis, prevention and treatment of ttv infections |
-
1999
- 1999-11-08 TN TNTNSN99210A patent/TNSN99210A1/fr unknown
- 1999-11-09 AU AU13816/00A patent/AU1381600A/en not_active Abandoned
- 1999-11-09 WO PCT/EP1999/008566 patent/WO2000028039A2/en not_active Application Discontinuation
- 1999-11-09 JP JP2000581206A patent/JP2002529092A/ja active Pending
- 1999-11-09 EP EP99971855A patent/EP1137779A2/en not_active Withdrawn
- 1999-11-10 AR ARP990105694A patent/AR021143A1/es not_active Application Discontinuation
- 1999-11-10 PE PE1999001137A patent/PE20001331A1/es not_active Application Discontinuation
-
2001
- 2001-05-09 NO NO20012276A patent/NO20012276L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1137779A2 (en) | 2001-10-04 |
| AU1381600A (en) | 2000-05-29 |
| NO20012276D0 (no) | 2001-05-09 |
| JP2002529092A (ja) | 2002-09-10 |
| NO20012276L (no) | 2001-07-09 |
| WO2000028039A2 (en) | 2000-05-18 |
| PE20001331A1 (es) | 2000-12-19 |
| AR021143A1 (es) | 2002-06-12 |
| WO2000028039A3 (en) | 2000-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kos et al. | Histidine-rich stabilized polyplexes for cMet-directed tumor-targeted gene transfer | |
| WO2003088979A2 (fr) | Oligonucleotide issus des sequences codant pour la composante de surface de proteines d'enveloppe des virus des lymphomes / leucemies t chez les primates (ptlv) et leurs utilisations | |
| JP2004511201A5 (es) | ||
| EP0984067A3 (en) | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents | |
| EP2298355A3 (en) | Albumin fusion proteins | |
| WO2005056584A3 (fr) | Nouvelle souche de coronavirus associe au sras et ses applications. | |
| TNSN99210A1 (fr) | Identification de genotypes du virus sen | |
| EP1394256A3 (en) | HCV genomic sequences for diagnostics and therapeutics | |
| JPS59500498A (ja) | １ａ型乳頭腫ウイルスゲノムのＬ１及びＬ２領域由来のＤＮＡ断片 | |
| JP2007516426A5 (es) | ||
| EP2390340A3 (en) | vector encoding Papillomavirus E1 and E2 polypeptides with reduced percentage of identity | |
| WO2003040187A1 (fr) | Anticorps monoclonaux du virus de l'hepatite e ou fragments liants en provenant et utilisation correspondante | |
| Young et al. | Different rat-derived transforming retroviruses code for an immunologically related intracellular phosphoprotein. | |
| WO2002072802A3 (en) | Live attenuated strains of prrs virus | |
| EP1613345A4 (en) | COMPOSITIONS AND METHODS WITH THE RESPIRATORY SYNCYTIAL VIRUS SUB-GROUP B STAMM 9320 | |
| WO1996021020A3 (en) | Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases | |
| WO2004014936A3 (fr) | Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications. | |
| EA200200743A1 (ru) | Рекомбинантное ослабление вируса репродуктивного и респираторного синдрома свиней (prrsv) | |
| Tognon et al. | Investigation of the simian polyomavirus SV40 as a potential causative agent of human neurological disorders in AIDS patients | |
| WO2004031222A3 (en) | Dna vaccine encoding at least two nonstructural early proteins of papillomavirus | |
| EP1383796A1 (fr) | Souche neurovirulente du virus west-nile et ses applications | |
| EP0743364A3 (fr) | Fragments d'acide nucléique dérivés du génome du virus VIH-1, peptides correspondants et leurs applications en tant que réactifs d'évaluation du risque de transmission materno-foetal du VIH-1 | |
| JP3656073B2 (ja) | 新規ネコ免疫不全ウイルス株及びその外被膜蛋白質遺伝子ｒｎａに対応するｄｎａ並びにネコ免疫不全ウイルスワクチン | |
| US20240002450A1 (en) | Antiviral structurally-stabilized ebolavirus peptides and uses thereof | |
| WO2003051174A3 (en) | Single nucleotide polymorphisms and mutations on alpha-2-macroglobulin |